Φορτώνει......
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
Dolutegravir (DTG) is a second-generation integrase strand transfer inhibitor (INSTI), which has now been licensed to be used in different countries including the UK. Earlier studies have demonstrated that DTG when used with nucleoside backbone in treatment-naïve and - experienced patients has been...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Infect Drug Resist |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4598225/ https://ncbi.nlm.nih.gov/pubmed/26491363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S68396 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|